EAU 2013 - Programme Book - YouMed

Friday, 15 March
Sponsored Session
16.15 - 17.45 Urological challenges in managing patients with angiomyolipoma
(AML)
Amber Hall 1-2 - Level S2
Symposium
Chair: K. Budde, Berlin (DE)
Welcome and introduction
K. Budde, Berlin (DE)
Case study presentation: Surgical option for the treatment of AML
A.L. Serra, Zurich (CH)
Overview of AML and the urologic challenges
B. Zonnenberg, Utrecht (NL)
Clinical data on mTOR inhibition for the management of AML
K. Budde, Berlin (DE)
Integrating surgical approaches with pharmacotherapy in the management of AML
M. Staehler, Munich (DE)
Case study: Individualising care for patients with TSC
A.L. Serra, Zurich (CH)
Panel discussion
Aims and objectives
• Increase understanding of current treatment approaches for the management of AML; the unmet needs;
and integration of current therapeutic approaches for the treatment of angiomyolipomas (AMLs) for
improved patient outcomes
• Increase the understanding of advances in the molecular basic of AML and the potential for integrating
pharmacotherapy into the management of AML
• Highlight the importance of treatment selection on an individualized, case-by-case basis
Sponsored by NOVARTIS ONCOLOGY
EAU Milan 2013
399
Sponsored Sessions